Search Results for "Otsuka Best Company List"
Original Source: The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ~ 57,747 Sanofi ~ 46,454 Novartis&n...
Matching Channels
The Top 100 Pharmaceutical Companies
The Top 100 Pharmaceutical Companies, determined by total sales in 2011 - see below for 2010 and 2009: They are listed in descending order with the sales in 2011 in $ million; Pfizer ...
At OncoDNA, our philosophy is to provide the most suitable test in terms of rapidity and cost. That’s why we follow a 3 tier approach to find tumour mutations which can respond to new cancer t...
Top 50 Biopharma Products 2011
Ronald A. Rader, president of the Biotechnology Information Institute provided Contract Pharma a list of the Top 57 Biopharma Products by 2011 revenues (in millions). Mr. Rader subscribes to the sam...
Matching News
Return to top 50 pharma list Summary Website: Otsuka Headquarters: Tokyo, Japan Ticker Symbol: OS1 (Frankfurt Stock Exchange) OTK (Frankfurt Stock Exchange) SEC Link: Otsuka Subsidiaries: Diatranz Ots...
CORRECTED-FDA approves once-monthly Abilify for schizophrenia
(Corrects stock symbol for Otsuka in paragraph 1 to for Otsuka Holdings Co Ltd from for Otsuka)
Lundbeck and Otsuka further expand their alliance and enter into collaboration
H. Lundbeck A/S (Lundbeck) and Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in developmen...
Lundbeck and Otsuka are biopharma partners again for Alzheimer’s treatment
Lundbeck and Otsuka , two big pharma companies, announced a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist currently in development for the treatment of Alzheim...
Otsuka chooses Catalent to supply OD tablets
Catalent has commenced supply to Otsuka Pharmaceutical of Abilify OD Tablets which utilize Catalent’s Zydis fast dissolve drug delivery technology. Otsuka has developed Abilify OD for the treatment...
Otsuka and Proteus Digital Health to develop digital health products
Proteus Digital Health and Otsuka Pharmaceutical have entered into an exclusive worldwide license and collaboration agreement to develop and commercialize a new category of medicines. Under the agreem...
Otsuka, Acucela JV Ready Phase III Trials Of Dry AMD Drug In Europe, U.S.
Otsuka Pharmaceutical is set to begin Phase III clinical trials in Europe and the United States with Acucela, a biotech begun by a Japanese ophthalmologist in the U.S. Otsuka is a major investor in th...
Lundbeck, Otsuka collaborate to develop Lu AE58054
Lundbeck and Otsuka Pharmaceuticals have signed a license and development agreement for Lu AE58054, a selective 5HT6 receptor antagonist for the treatment of Alzheimer's disease.
Matching PubMed Articles
In list-method directed forgetting, people are cued to forget a previously studied item list and to learn a new list instead. Such cuing typically leads to forgetting of the first list and to memory e...
Evidence for noisy contextual search: Examining the dynamics of list-before-last recall.
The dynamics of free recall in the list-before-last task were examined in the current study. List-length was manipulated and probability of recall was influenced by target list-length but not by inter...
PURPOSE: To assess the rationality of the Mexican Formulary List (MEX-LIST). METHODS: MEX-LIST was compared with the World Health Organization Essential Medicines List (WHO-LIST) to identify drugs cla...
List-method directed forgetting involves encoding 2 lists, between which half of the participants are told to forget List 1. When participants are free to study however they want, directed forgetting...
The production effect in memory: Evidence that distinctiveness underlies the benefit.
The production effect is the substantial benefit to memory of having studied information aloud as opposed to silently. MacLeod, Gopie, Hourihan, Neary, and Ozubko (2010) have explained this enhancemen...